1. |
Jennings ER, Hindmarsh C. Hemagglutination test for viral hepatitis with special reference to nonspecific reactions[J]. J Lab Clin Med, 1960; 55: 519-521.
|
2. |
Suzuki F, Hashikura Y, Ise H, et al. MCI-186 (edaravone), a free radical scavenger, attenuates hepatic warm ischemia-reperfusion injury in rats [J]. Transpl Int, 2005; 18(7): 844-853.
|
3. |
Nakatani K, Kaneda K, Seki S, et al. Pit cells as liver-associated natural killer cells: morphology and function [J]. Med Electron Microsc, 2004; 37(1): 29-36.
|
4. |
Teoh N, Field J, Sutton J, et al. Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice [J]. Hepatology, 2004; 39(2): 412-421.
|
5. |
Zhai Y, Shen XD, Hancock WW, et al. CXCR3+CD4+ T cells mediate innate immune function in the pathophysiology of liver ischemia/reperfusion injury [J]. J Immunol, 2006; 176(10): 6313-6322.〖JP〗.
|
6. |
Fischer M, Harvima IT, Carvalho RF, et al. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion [J]. J Clin Invest, 2006; 116(10): 2748-2756.
|
7. |
Odashima M, Otaka M, Jin M, et al. Selective A2A adenosine agonist ATL-146e attenuates acute lethal liver injury in mice [J]. J Gastroenterol, 2005; 40(5): 526-529.
|
8. |
Mizuguchi H, Hayakawa T. Targeted adenovirus vectors [J]. Hum Gene Ther, 2004; 15(11): 1034-1044.
|
9. |
Savransky V, Molls RR, Burne-Taney M, et al. Role of the T-cell receptor in kidney ischemia-reperfusion injury [J]. Kidney Int, 2006; 69(2): 233-238.
|
10. |
Ke B, Shen XD, Gao F, et al. Interleukin 13 gene transfer in liver ischemia and reperfusion injury: role of Stat6 and TLR4 pathways in cytoprotection [J]. Hum Gene Ther, 2004; 15(7): 691-698.
|
11. |
Berberat PO, Katori M, Kaczmarek E, et al. Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury [J]. FASEB J, 2003; 17(12): 1724-1726.
|
12. |
Caldwell CC, Okaya T, Martignoni A, et al. Divergent functions of CD4+ T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion [J]. Am J Physiol Gastrointest Liver Physiol, 2005; 289(5): G969-G976.
|
13. |
Day YJ, Marshall MA, Huang L, et al. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction [J]. Am J Physiol Gastrointest Liver Physiol, 2004; 286(2): G285-G293.
|
14. |
Zhang M, Alicot EM, Chiu I, et al. Identification of the target self-antigens in reperfusion injury [J]. J Exp Med, 2006; 203(1): 141-152.
|
15. |
Gao W, Bentley RC, Madden JF, et al. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation [J]. Hepatology, 1998; 27(6): 1652-1660.
|
16. |
Bilbao G, Contreras JL, Eckhoff DE, et al. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene [J]. Ann Surg, 1999; 230(2): 185-193.
|
17. |
Barrier A, Olaya N, Chiappini F, et al. Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion [J]. FASEB J, 2005; 19(12): 1617-1626.
|
18. |
Ma W, Wang ZR, Shi L, et al. Expression of macrophage inflammatory protein-1 alpha in Kupffer cells following liver ischemia or reperfusion injury in rats [J]. World J Gastroenterol, 2006; 12(24): 3854-3858.
|
19. |
Sawitzki B, Amersi F, Ritter T, et al. Upregulation of Bag-1 by ex vivo gene transfer protects rat livers from ischemia/reperfusion injury [J]. Hum Gene Ther, 2002; 13(12): 1495-1504.
|
20. |
El-Ghoneimi A, Cursio R, Schmid-Alliana A, et al. Inhibition of tumor necrosis factor alpha gene transcription by pentoxifylline reduces normothermic liver ischemia-reperfusion injury in rats [J]. Transplant Proc, 2007; 39(6): 1761-1764.
|
21. |
Ke B, Shen XD, Tsuchihashi S, et al. Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity [J]. 〖JP4〗Hum Gene Ther, 2007; 18(4): 355-366.
|
22. |
Zwacka RM, Zhou W, Zhang Y, et al. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation [J]. Nat Med, 1998; 4(6): 698-704.
|
23. |
Wheeler MD, Katuna M, Smutney OM, et al. Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury [J]. Hum Gene Ther, 2001; 12(18): 2167-2177.
|
24. |
Katori M, Buelow R, Ke B, et al. Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway [J]. Transplantation, 2002; 73(2): 287-292.
|
25. |
Soares MP, Lin Y, Anrather J, et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival [J]. Nat Med, 1998; 4(9): 1073-1077.
|
26. |
Otterbein LE, Kolls JK, Mantell LL, et al. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury [J]. J Clin Invest, 1999; 103(7): 1047-1054.
|
27. |
Kuboki S, Schuster R, Blanchard J, et al. Role of heat shock protein 70 in hepatic ischemia-reperfusion injury in mice [J]. Am J Physiol Gastrointest Liver Physiol, 2007; 292(4): G1141-G1149.
|
28. |
王科, 王学浩, 张峰, 等. 诱导HO-1改善氧化应激状态减轻老年供肝缺血再灌注损伤 [J]. 中国普外基础与临床杂志, 2005; 12(2): 109-112.
|
29. |
Shen SQ, Zhang Y, Xiang JJ, et al. Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes [J]. World J Gastroenterol, 2007; 13(13): 1953-1961.
|
30. |
Zuo Z, Wang C, Carpenter D, et al. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection [J]. Transplantation, 2001; 71(5): 686-691.
|
31. |
Ke B, Shen XD, Lassman CR, et al. Cytoprotective and antiapoptotic effects of IL-13 in hepatic cold ischemia/reperfusion injury are heme oxygenase-1 dependent [J]. Am J Transplant, 2003; 3(9): 1076-1082.
|
32. |
Evans PC, Kilshaw PJ. Interleukin-13 protects endothelial cells from apoptosis and activation: association with the protective genes A20 and A1 [J]. Transplantation, 2000; 70(6): 928-934.
|
33. |
Kim YI, Song KE, Ryeon HK, et al. Enhanced inflammatory cytokine production at ischemia/reperfusion in human liver resection [J]. Hepatogastroenterology, 2002; 49(46): 1077-1082.
|
34. |
Ahmed-Choudhury J, Russell CL, Randhawa S, et al. Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation [J]. Mol Biol Cell, 2003; 14(4): 1334-1345.
|
35. |
Nikolaidou-Neokosmidou V, Zannis VI, Kardassis D. Inhibition of hepatocyte nuclear factor 4 transcriptional activity by the nuclear factor kappaB pathway [J]. Biochem J, 2006; 398(3): 439-450.
|
36. |
Takahashi Y, Ganster RW, Ishikawa T, et al. Protective role of NF-kappaB in liver cold ischemia/reperfusion injury: effects of IkappaB gene therapy [J]. Transplant Proc, 2001; 33(1-2): 602.
|
37. |
Shen XD, Ke B, Zhai Y, et al. CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection [J]. Transplantation, 2002; 74(3): 315-319.
|
38. |
Shen XD, Ke B, Zhai Y, et al. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection [J]. Hepatology, 2003; 37(2): 296-319.
|
39. |
Ke B, Shen XD, Gao F, et al. Gene therapy for liver transplantation using adenoviral vectors: CD40-CD154 blockade by gene transfer of CD40Ig protects rat livers from cold ischemia and reperfusion injury [J]. Mol Ther, 2004; 9(1): 38-45.
|
40. |
Sato Y, Ajiki T, Inoue S, et al. Gene silencing in rat-liver and limb grafts by rapid injection of small interference RNA [J]. Transplantation, 2005; 79(2): 240-243.
|
41. |
Soutschek J, Akinc A, Bramlage B, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs [J]. Nature, 2004; 432(7014): 173-178.
|